Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BN-Brachyury and Radiation in Advanced Chordoma
NCT03595228Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Oct 2018
- Primary completion
- Dec 2021
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of MVA-BN-Brachyury in chordoma, sponsored by Bavarian Nordic. Primary endpoint: Objective Response Rate. Started Oct 2018; status: completed.
02
Drugs
MVA-BN-Brachyury
03
Conditions
chordoma
Beyond the preview
Go deeper on NCT03595228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595228.